David J. Benjamin

1.0k total citations
77 papers, 647 citations indexed

About

David J. Benjamin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, David J. Benjamin has authored 77 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 20 papers in Surgery. Recurrent topics in David J. Benjamin's work include Bladder and Urothelial Cancer Treatments (14 papers), Economic and Financial Impacts of Cancer (12 papers) and Urinary and Genital Oncology Studies (11 papers). David J. Benjamin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Economic and Financial Impacts of Cancer (12 papers) and Urinary and Genital Oncology Studies (11 papers). David J. Benjamin collaborates with scholars based in United States, United Kingdom and France. David J. Benjamin's co-authors include Mark P. Lythgoe, Vinay Prasad, Ashok Agarwal, Arash Rezazadeh Kalebasty, Joseph J. Sanger, E Douglas Kramer, Stefan S. du Plessis, Satya Prakash Yadav, Riles Ts and Brian A. Jonas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David J. Benjamin

63 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Benjamin United States 14 182 148 133 130 101 77 647
Shu‐Fang Hsu Schmitz Switzerland 16 94 0.5× 185 1.3× 109 0.8× 421 3.2× 30 0.3× 34 980
Basile Chrétien France 11 183 1.0× 207 1.4× 111 0.8× 530 4.1× 49 0.5× 48 921
Johan Bjerner Norway 15 146 0.8× 44 0.3× 195 1.5× 111 0.9× 148 1.5× 30 681
MW Beckmann Germany 18 130 0.7× 120 0.8× 156 1.2× 272 2.1× 220 2.2× 133 1.1k
Shiyou Wei China 18 169 0.9× 245 1.7× 255 1.9× 158 1.2× 71 0.7× 53 921
Jae Il Chung South Korea 14 191 1.0× 292 2.0× 182 1.4× 109 0.8× 29 0.3× 45 644
Phui‐Ly Liew Taiwan 17 241 1.3× 142 1.0× 193 1.5× 72 0.6× 50 0.5× 38 669
Vincent Dochez France 10 165 0.9× 70 0.5× 154 1.2× 116 0.9× 235 2.3× 47 692
Katarzyna Drabko Poland 14 77 0.4× 199 1.3× 83 0.6× 86 0.7× 10 0.1× 78 498
Eun Hyo Jin South Korea 16 266 1.5× 306 2.1× 155 1.2× 350 2.7× 109 1.1× 66 913

Countries citing papers authored by David J. Benjamin

Since Specialization
Citations

This map shows the geographic impact of David J. Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Benjamin more than expected).

Fields of papers citing papers by David J. Benjamin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Benjamin. The network helps show where David J. Benjamin may publish in the future.

Co-authorship network of co-authors of David J. Benjamin

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Benjamin. A scholar is included among the top collaborators of David J. Benjamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Benjamin. David J. Benjamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benjamin, David J., et al.. (2025). The role of dietary sugars in cancer risk: A comprehensive review of current evidence. Cancer Treatment and Research Communications. 43. 100876–100876. 2 indexed citations
2.
Jabbari, Parnian, et al.. (2025). The Role of Ayurveda in Prostate Cancer Management. Integrative Cancer Therapies. 24. 1583646042–1583646042. 1 indexed citations
3.
Benjamin, David J., et al.. (2025). Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy. Frontiers in Oncology. 14. 1457006–1457006.
5.
Benjamin, David J., Mark P. Lythgoe, & Arash Rezazadeh Kalebasty. (2024). Hollywood's Take on Oncology: Portrayal of Cancer in Movies, 2010-2020. JCO Oncology Practice. 20(4). 457–459. 2 indexed citations
6.
Jabbari, Parnian, et al.. (2024). Supplement Use and Increased Risks of Cancer: Unveiling the Other Side of the Coin. Cancers. 16(5). 880–880. 9 indexed citations
7.
Benjamin, David J., et al.. (2024). A narrative review on perioperative systemic therapy in non-small cell lung cancer. SHILAP Revista de lepidopterología. 5(4). 931–954. 3 indexed citations
8.
Benjamin, David J., et al.. (2024). Trends in incidence and demographics of testicular cancer in California, 2000–2020. SHILAP Revista de lepidopterología. 5(12). 1249–1251. 1 indexed citations
9.
Benjamin, David J., et al.. (2023). Treatment approaches for FGFR-altered urothelial carcinoma: targeted therapies and immunotherapy. Frontiers in Immunology. 14. 1258388–1258388. 10 indexed citations
10.
Benjamin, David J. & Arash Rezazadeh Kalebasty. (2023). Treatment approaches for urachal cancer: Use of immunotherapy and targeted therapies. SHILAP Revista de lepidopterología. 15. 754782176–754782176. 4 indexed citations
11.
Benjamin, David J., et al.. (2023). The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer—A Narrative Review. Cancers. 15(14). 3561–3561. 11 indexed citations
13.
Benjamin, David J. & Mark P. Lythgoe. (2023). The FDA’s latest draft guidance on accelerated approvals — one step forward, two steps back?. Nature Reviews Clinical Oncology. 20(9). 577–578. 7 indexed citations
14.
Benjamin, David J., et al.. (2023). Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry. Prostate Cancer and Prostatic Diseases. 27(4). 680–685. 1 indexed citations
15.
Kumar, Priyanka, et al.. (2022). Eponyms in Malignant Hematology. Cancer Treatment and Research Communications. 32. 100594–100594. 1 indexed citations
16.
Benjamin, David J. & Misako Nagasaka. (2022). Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance Against Osimertinib (FLAURA)?. Journal of Clinical Oncology. 41(4). 742–744. 4 indexed citations
17.
Benjamin, David J., et al.. (2022). Targeted therapy in lung cancer: Are we closing the gap in years of life lost?. Cancer Medicine. 11(18). 3417–3424. 9 indexed citations
18.
Benjamin, David J., Nataliya Mar, & Arash Rezazadeh Kalebasty. (2022). Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma. Clinical Medicine Insights Oncology. 16. 1363247212–1363247212. 10 indexed citations
19.
Benjamin, David J. & Arash Rezazadeh. (2022). Quality of life in sexual minorities following prostate cancer treatment. Nature Reviews Urology. 19(6). 323–324. 2 indexed citations
20.
Benjamin, David J. & Yung Lyou. (2021). Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer. Cancers. 13(22). 5724–5724. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026